Bioqual (OTCMKTS:BIOQ) Announces Earnings Results

Bioqual (OTCMKTS:BIOQ) issued its quarterly earnings results on Friday. The company reported $1.05 earnings per share for the quarter, Zacks reports. Bioqual had a negative net margin of 5.54% and a negative return on equity of 7.50%.

Bioqual Price Performance

BIOQ stock remained flat at $55.00 during midday trading on Friday. The business’s fifty day simple moving average is $58.98 and its two-hundred day simple moving average is $63.80. Bioqual has a 1-year low of $55.00 and a 1-year high of $77.00. The company has a market cap of $49.17 million, a PE ratio of -17.57 and a beta of -0.03.

About Bioqual

Bioqual, Inc provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer.